Deirdre Cohen, MD
- SENIOR FACULTY | Medicine, Hematology and Medical Oncology
- Cancer (Oncology)
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Queens
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
Deirdre J. Cohen, MD, MS, serves as the Director of the Gastrointestinal (GI) Oncology Program for the Mount Sinai Health System and is an Associate Professor of Medicine (Hematology and Medical Oncology). She is also Medical Director of the Cancer Clinical Trials Office at The Tisch Cancer Institute.
Dr. Cohen is an expert in pancreatic and gastrointestinal cancers and has been awarded both federal and non-federal funding for research in these malignancies. Dr. Cohen takes a multi-disciplinary approach to patient care, working with a team of providers, and places importance on a supportive and individualized care plan for each of her patients.
As Director of the GI Oncology Program, Dr. Cohen fosters important translational and clinical research including studies that build upon scientific discoveries at Mount Sinai and collaborating institutions. As Medical Director of the Cancer Clinical Trials Office, she spearheads the initiation and conduct of clinical trials that improve the lives of cancer patients and benefit the cancer community at large.
Dr. Cohen conducts research focused on immune targeted strategies and biomarker-driven studies with translational endpoints, and serves as principal investigator on many clinical trials pertaining to novel therapeutic approaches for patients with GI malignancies. She is a member of numerous national committees focused on the advancement of clinical research, including the National Cancer Institute’s colon task force.
- Colon Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastrointestinal Cancers
- Liver Cancer
- Pancreatic Cancer
- Stomach Cancer
BS, Cornell University
MD, SUNY Health Science Center at Brooklyn
MS, New York University
Residency, Internal Medicine
NYP Weill Cornell
NYU Langone Medical Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Cohen did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.